Health Management

Diabetes accounts for one out of every 10 American healthcare dollars spent, but new national programs are helping address this issue.

Study: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia.

A Cleveland Clinic study examines the mortality burden of modifiable behavioral risk factors such as obesity, diabetes, tobacco use, high blood pressure and high cholesterol.

New findings reveal this genetic test to assess breast cancer risk could be more effective than others.

A new Commonwealth Fund survey on how Medicaid changes could affect this population, has experts weighing in on ways to resolve the healthcare disconnect.

Nationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project.

A new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.

CVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.

One thing that is unlikely to change under the new Administration is the goal of reducing the cost of healthcare through various alternative payment initiatives. Here’s how that will affect oncology.

The call for antimicrobial stewardship is growing. Enact these steps to prevent a return to the pre-antibiotic era.

Blue Cross Blue Shield of Illinois partners with gastroenterology group to focus on Crohn’s disease patients.

With a growing need for services, nearly nine in 10 employers cite behavioral health as an important priority in Willis Towers Watson survey.

Two studies, one from Prime Therapeutics and Stanford, reveal an alarming increase in overdose with concurrent use of opioids and benzodiazepines. Here’s how managed care can help.

The healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.

The healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.

Chief experience officers improve the patient experience-and the experience of caregivers.

Just last year, the FDA approved Exondys 51 (eteplirsen) for DMD, over the recommendations of FDA scientists and an external scientific advisory committee. Read more.

Oncology is a complex and rapidly-evolving management challenge for payers.

Patient risk can improve value-based cancer care. Find out how.

A study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States.

Here are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions.

Here are four ways that health plans can improve their internal processes for collecting provider data.

With ACA repeal and replace on the horizon, digital healthcare solutions will surely be affected.

A West survey finds that an overwhelming number of chronic care patients say they need help managing their disease.

Innovation in healthcare wearables continues to drive market growth.